Zyprexa® Relprevv™ Patient Care Program

Enrolling by invitation

Conditions studied: Schizophrenia

In brief

The goal of the Zyprexa Relprevv Patient Care Program is to mitigate the risk of negative outcomes associated with Zyprexa Relprevv post-injection delirium/sedation syndrome (PDSS).

Key facts

Study ID

NCT01088386

Run by

Eli Lilly and Company

People needed

4000

Starts

2010-03-03

Expected to finish

2026-06-01

Last updated by the study team

2026-01-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any patients receiving Zyprexa Relprevv enrolled in Zyprexa Relprevv Patient Care Program

You may not qualify if…

• Any patient not receiving Zyprexa Relprevv

Where it is running

• United BioSource Corporation — Blue Bell, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.